Tevogen Bio Advocates for Long COVID Patients in Congressional Meetings

2 Sources

Tevogen Bio's leadership met with U.S. Congress members to discuss Long COVID patient advocacy and showcase the company's innovative biotech model. The meetings highlighted Tevogen's achievements and potential impact on the biotech industry.

News article

Tevogen Bio Engages with Congress on Long COVID

Tevogen Bio, a clinical-stage biotechnology company, has taken a significant step in advocating for Long COVID patients by meeting with members of the United States Congress. The company's leadership, including CEO Ryan Saadi, M.D., M.P.H., engaged in discussions with congressional representatives to address the pressing needs of those suffering from Long COVID and to highlight Tevogen's innovative approach to biotechnology 1.

Advocating for Long COVID Patients

The meetings focused on raising awareness about the challenges faced by Long COVID patients and the importance of continued research and support. Tevogen Bio emphasized the need for increased attention and resources to address this growing health concern, which affects millions of Americans 2.

Showcasing Innovative Biotech Model

During the congressional meetings, Tevogen Bio presented its achievements and assets as a blueprint for biotech innovation. The company highlighted its unique business model, which aims to develop transformative immunotherapies while maintaining fiscal responsibility and operational efficiency 1.

Key Achievements and Assets

Tevogen Bio showcased several notable accomplishments:

  1. Development of a diverse pipeline of next-generation precision T cell therapeutics
  2. Advancement of its lead product, TVGN-489, for Long COVID treatment to phase 1 clinical trials
  3. Establishment of a robust intellectual property portfolio
  4. Creation of a state-of-the-art R&D center in Philadelphia
  5. Formation of strategic collaborations with leading academic institutions 2

Impact on Biotech Industry

The company's leadership emphasized how Tevogen's model could serve as a template for other biotech firms, potentially revolutionizing the industry's approach to drug development and commercialization. By focusing on efficiency and cost-effectiveness, Tevogen aims to make advanced therapies more accessible to patients worldwide 1.

Future Prospects and Collaborations

Tevogen Bio expressed its commitment to continuing its advocacy efforts and expanding its research initiatives. The company plans to leverage its congressional meetings to foster new partnerships and collaborations that could accelerate the development of treatments for Long COVID and other unmet medical needs 2.

Explore today's top stories

Elon Musk's xAI Open-Sources Grok 2.5, Promises Grok 3 Release in Six Months

Elon Musk's AI company xAI has open-sourced the Grok 2.5 model on Hugging Face, making it available for developers to access and explore. Musk also announced plans to open-source Grok 3 in about six months, signaling a commitment to transparency and innovation in AI development.

TechCrunch logoengadget logoDataconomy logo

7 Sources

Technology

18 hrs ago

Elon Musk's xAI Open-Sources Grok 2.5, Promises Grok 3

Nvidia Unveils Plans for Light-Based GPU Interconnects by 2026, Revolutionizing AI Data Centers

Nvidia announces plans to implement silicon photonics and co-packaged optics for AI GPU communication by 2026, promising higher transfer rates and lower power consumption in next-gen AI data centers.

Tom's Hardware logoDataconomy logo

2 Sources

Technology

2 hrs ago

Nvidia Unveils Plans for Light-Based GPU Interconnects by

Netflix Unveils Generative AI Guidelines for Content Creation

Netflix has released new guidelines for using generative AI in content production, outlining low-risk and high-risk scenarios and emphasizing responsible use while addressing industry concerns.

Mashable logoDataconomy logo

2 Sources

Technology

2 hrs ago

Netflix Unveils Generative AI Guidelines for Content

Breakthrough in Spintronics: Turning Spin Loss into Energy for Ultra-Low-Power AI Chips

Scientists at KIST have developed a new device principle that utilizes "spin loss" as a power source for magnetic control, potentially revolutionizing the field of spintronics and paving the way for ultra-low-power AI chips.

ScienceDaily logonewswise logo

2 Sources

Technology

2 hrs ago

Breakthrough in Spintronics: Turning Spin Loss into Energy

Cloudflare Unveils New Zero Trust Tools for Secure AI Adoption in Enterprises

Cloudflare introduces new features for its Cloudflare One zero-trust platform, aimed at helping organizations securely adopt, build, and deploy generative AI applications while maintaining security and privacy standards.

SiliconANGLE logoMarket Screener logo

2 Sources

Technology

2 hrs ago

Cloudflare Unveils New Zero Trust Tools for Secure AI
TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo